Evidence map›Paper›PMID 34869075›Full record

ArticleFrontiers in cellular and infection microbiology2021

Characterization of Naturally Acquired Immunity to a Panel of Antigens Expressed in Mature

Michelle K Muthui, Eizo Takashima, Brian R Omondi, Christine Kinya, William I Muasya, Hikaru Nagaoka, Kennedy W Mwai, Benedict Orindi, Juliana Wambua, Teun Bousema and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Frontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in cellular and infection microbiology · 2022
    Review
  8. Article
  9. Identification of Novel Malaria Transmission-Blocking Vaccine Candidates.Frontiers in cellular and infection microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 5 countries.

Michelle K MuthuiDepartment of Biosciences, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Programme, Kilifi, Kenya.
Eizo TakashimaDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan.
Brian R OmondiDepartment of Biosciences, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Programme, Kilifi, Kenya.
Christine KinyaDepartment of Biosciences, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Programme, Kilifi, Kenya.
William I MuasyaDepartment of Biosciences, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Programme, Kilifi, Kenya.
Hikaru NagaokaDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama, Japan.
Kennedy W MwaiDepartment of Biosciences, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Programme, Kilifi, Kenya.
Benedict OrindiDepartment of Biosciences, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Programme, Kilifi, Kenya.
Juliana WambuaDepartment of Biosciences, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Programme, Kilifi, Kenya.
Teun BousemaDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands.
Chris DrakeleyDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Andrew M BlagboroughDivision of Microbiology and Parasitology, Department of Pathology, Cambridge University, Tennis Court Road, Cambridge, United Kingdom.
Kevin MarshCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Philip BejonDepartment of Biosciences, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Programme, Kilifi, Kenya.
Melissa C KapuluDepartment of Biosciences, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Programme, Kilifi, Kenya.
Kenya Medical Research Institute · KEEhime University · JPLondon School of Hygiene & Tropical Medicine · GBRadboud University Medical Center · NLUniversity of Cambridge · GBUniversity of Oxford · GBUniversity of the Witwatersrand · ZA

Funding

Medical Research Council MR/N00227X/1Wellcome Trust
6 · The paper itself

Abstract

Introduction: Naturally acquired immune responses against antigens expressed on the surface of mature gametocytes develop in individuals living in malaria-endemic areas. Evidence suggests that such anti-gametocyte immunity can block the development of the parasite in the mosquito, thus playing a role in interrupting transmission. A better comprehension of naturally acquired immunity to these gametocyte antigens can aid the development of transmission-blocking vaccines and improve our understanding of the human infectious reservoir. Methods: Antigens expressed on the surface of mature gametocytes that had not previously been widely studied for evidence of naturally acquired immunity were identified for protein expression alongside Pfs230-C using either the mammalian HEK293E or the wheat germ cell-free expression systems. Where there was sequence variation in the candidate antigens (3D7 Results: Of the 25 antigens selected, seven antigens were produced successfully as recombinant proteins, with one variant antigen, giving a total of eight proteins for evaluation. Antibodies to the candidate antigens were detectable in the study population (N = 216), with seroprevalence ranging from 37.0% (95% CI: 30.6%, 43.9%) for PSOP1 to 77.8% (95% CI: 71.6%, 83.1%) for G377 (3D7 variant). Responses to AMA1 and GE were more prevalent than those to the gametocyte proteins at 87.9% (95% CI: 82.8%, 91.9%) and 88.3% (95% CI: 83.1%, 92.4%), respectively. Additionally, both antibody levels and breadth of antibody responses were associated with age and concurrent parasitaemia. Conclusion: Age and concurrent parasitaemia remain important determinants of naturally acquired immunity to gametocyte antigens. Furthermore, we identify novel candidates for transmission-blocking activity evaluation.

Indexed as

Malaria, FalciparumAnimalsAntibodies, ProtozoanAntibody FormationAntigens, ProtozoanHumansPlasmodium falciparumProtozoan ProteinsSeroepidemiologic StudiesAntibodies, ProtozoanAntigens, ProtozoanProtozoan Proteinsmalaria transmissionmature gametocytesnaturally acquired immunityPlasmodium falciparumseroepidemiology

Identifiers

PMID34869075
PMCPMC8633105
OpenAlexW3211945741

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.